The influence of a standardized soybean extract (Glycine max) on the expression level of cytochrome P450 genes in vivo;Wpływ standaryzowanego ekstraktu sojowego (Glycine max) na poziom ekspresji cytochromu P450 in vivo

Ginekologia Polska

Volumn 81, Issue 7, 2010, Pages 516-520

  Mrozikiewicz, Przemyslaw M ^a,b   Anna, Bogacz ^a,b   Boguslaw, Czerny ^b,c   Monika, Karasiewicz ^b   Radoslaw, Kujawski ^b   Mikolajczak, Przemysław L ^a,b   Agnieszka, Seremak Mrozikiewicz ^a   Edmund, Grzeskowiak ^a   Teresa, Bobkiewicz Kozlowska ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytochrome P450; Expression level; Interactions; Rat model; Soybean

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; ISOFLAVONE DERIVATIVE; MESSENGER RNA; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENETICS; MALE; METABOLISM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOYBEAN; SPRAGUE DAWLEY RAT;

ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; ISOFLAVONES; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOYBEANS;

EID: 77958192446     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Messina M. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr. 1999, 70, Suppl. 3, 439-450.
2. Kurzer M, Xu X. Dietary phytoestrogens. Annu Rev Nutr. 1997, 17, 353-381.
3. Messina M, Loprinzi C. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001, 131, 3095-3108.
4. Persky V, Van Horn L. Epidemiology of soy and cancer: perspectives and directions. J Nutr. 1995, 125, Suppl 3, 709-712.
5. Dennison E, Yoshimura N, Hashimoto T, [et al.]. Bone loss in Great Britain and Japan: a comparative longitudinal study. Bone. 1998, 23, 379-382.
6. Potter S, Baum J, Teng H, [et al.]. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998, 68, 1375-1379.
7. Uesugi T, Toda T, Tsuji K, [et al.]. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzein, genistein, and glycitin. Biol Pharm Bull. 2001, 24, 368-372.
8. Knight D, Howes J, Eden J. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric. 1999, 2, 79-84.
9. Anderson J, Johnstone B, Cook-Newell M, [et al.]. Meta-analysis of the effect of soy protein intake on serum lipids. N Engl J Med. 1995, 333, 276-282.
10. Lamartiniere C, Zhang J, Cotroneo M. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr. 1998, 68, Suppl. 6, 1400-1405.
11. Prestera T, Holtzclaw W, Zhang Y, [et al.]. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci U S A. 1993, 90, 2965-2969.
12. Guengerich F. Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals. Annu Rev Nutr. 1984, 4, 207-231.
13. Ma M, Woo M, Mcleod H. Genetic basis of drug metabolism. Am J Health Syst Pharm. 2002, 59, 2061-2069.
14. Ronis M, Ingelman-Sundberg M. Induction of human P450 enzymes: mechanisms and implications. Handbook of Human Toxicology. Wool TA. Marcel Decker New York. 1998, 239-262.
15. Westlind-Johnsson A, Malmebo S, Johansson A, [et al.]. Comparative analysis of CYP3A expression in human liver suggest only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos. 2003, 31, 755-761.
16. Van Vleet T, Klein P, Coulombe R. Metabolism and cytotoxicity of aflatoxin B1 in cytochrome p450-expressing human lung cells. J Toxicol Environ Health. 2002, 65A, 853-867.
17. Yamazaki H, Inui Y, Wrighton S, [et al.]. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis. 1995, 16, 2167-2170.
18. Zheng W, Jin F, Dunning L, [et.al]. Epidemiological study of urinary 6Beta-hydroxycortisol to cortisol ratios and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001, 10, 237-242.
19. Riddick D, Lee C, Bhathena A, [et al.]. Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab Dispos. 2004, 32, 367-375.
20. Van Iersel M, Verhagen H, Van Bladeren P. The role of biotransformation in dietary (anti)carcinogenesis. Mutat Res. 1999, 443, 259-270.
21. Hodek P, Trefl P, Stiborova M. Flavonoids - potent and versatile biologically active compounds interacting with cytochrome P450. Chem Biol Interact. 2002, 139, 1-21.
22. Mrozikiewicz P, Bogacz A, Karasiewicz M, [et al.]. The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level. Phytomedicine. 2010, 17, 830-833.
23. Dorne J. Walton K, Renwick A. Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem Toxicol. 2003, 41, 201-224.
24. Anzenbacher P, Anzenbacherová E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci. 2001, 58, 737-747.
25. Ronis MJ, Rowlands JC, Hakkak R, [et al.]. Inducibility of hepatic CYP1A enzymes by 3-methylcholanthrene and isosafrole differs in male rats fed diets containing casein, soy protein isolate or whey from concentration to adulthood. J Nutr. 2001, 131, 1180-1188.
26. Laurenzana E, Weis C, Bryant C, [et al.]. Effect of dietary administration of genistein, nonylphenol or ethinyl estradiol on hepatic testosterone metabolism, cytochrome P-450 enzymes, and estrogen receptor alpha expression. Food Chem Toxicol. 2002, 40, 53-63.
27. Helsby N, Chipman J, Gescher A, [et al.]. Inhibition of mouse and human CYP 1A-and 2E1 -dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol. 1998, 36, 375-382.
28. Anderson G, Rosito G, Mohustsy M, [et al.]. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol. 2003, 43, 643-648.
29. Ronis M, Chen Y, Jo C, [et al.]. Diets containing soy protein isolate increase hepatic CYP3A expression and inducibility in weanling male rats exposed during early development. J Nutr. 2004, 134, 3270-3276.
30. Li Y, Shay N. Isoflavone-drug interactions in HepG2 cells and human hepatocytes. FASEB J. 2004, 18, A851.
31. Roberts-Kirchof E, Crowley J, Hollenberg P, [et al.]. Metabolism of genistein by rat and human cytochrome P450s. Chem Res Toxicol. 1999, 12, 610-616.
32. Helsby N, Williams J, Kerr D, [et al.]. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. Xenobiotica. 1997, 27, 587-596.
33. Kishida T, Nashiki K, Izumi T, [et al.]. Soy isoflavonoid aglycons genistein and daidzein do not increase the cytochrome P-450 content of the liver microsomes of mice. J Agric Food Chem. 2000, 48, 3872-3875.
34. Kishida T, Nagamoto M, Ohtsu Y, [et al.]. Lack of an Inducible Effect of Dietary Soy Isoflavones on the mRNA Abundance of Hepatic Cytochrome P-450 Isozymes in Rats. Biosci Biotechnol Biochem. 2004, 68, 508-515.
35. Adlercreutz C, Goldin B, Gorbach S, [et al.]. Soybean phytoestrogen intake and cancer risk. J Nutr. 1995, 125, Suppl. 3, 757-770.
36. Ross P, Norimatsu H, Davis J, [et al.]. A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol. 1991, 133, 801-809.